A Form 4 filed with the SEC on August 14, 2026, discloses that Pablo J. Cagnoni, President and Global Head of R&D at Incyte Corp (NASDAQ:INCY), disposed of 10,803 shares of common stock on August 12, 2026, pursuant to a Rule 10b5-1 trading plan.
Key Highlights
- Reporting person: Pablo J. Cagnoni, President, Global Head of R&D at Incyte Corp
- Transaction: 10,803 shares of common stock disposed of (transaction code S) on August 12, 2026
- Sale price: $120.04 per share
- Post-transaction ownership: 194,001 shares of common stock beneficially owned directly
- Unvested units included: 183,200 of those shares are issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested
- 10b5-1 plan: The transaction was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c)
Cagnoni's Share Sale and Remaining Stake at Incyte Corp
According to the filing, Pablo J. Cagnoni, who serves as President and Global Head of R&D at Incyte Corp, sold 10,803 shares of Incyte common stock on August 12, 2026, at a price of $120.04 per share. The filing indicates the transaction was carried out under a pre-established Rule 10b5-1(c) trading plan, as noted by the checked box on the form.
Following the reported transaction, Cagnoni held 194,001 shares of common stock directly. The filing includes a footnote clarifying that 183,200 of those shares represent common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not yet vested. The form was signed by Elizabeth Feeney as Attorney-in-Fact and filed on August 14, 2026.
No derivative securities transactions were reported in Table II of the filing. The form was filed by one reporting person and covers a single open-market sale in non-derivative common stock.
What Was Disclosed
The filing reports a single sale of 10,803 shares of Incyte Corp common stock by executive Pablo J. Cagnoni on August 12, 2026, at $120.04 per share, executed under a Rule 10b5-1 plan, leaving him with 194,001 shares beneficially owned directly.




Please wait processing your request...